Header Logo

Connection

STEPHEN PFLUGFELDER to Treatment Outcome

Back to Details
This is a "connection" page, showing publications STEPHEN PFLUGFELDER has written about Treatment Outcome.
STEPHEN PFLUGFELDER
Connection Strength
0.378
Treatment Outcome
  1. Combined therapy of ocular surface disease with plasma rich in growth factors and scleral contact lenses. Ocul Surf. 2022 01; 23:162-168.
    View in: PubMed
    Score: 0.060
  2. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Ophthalmology. 2020 01; 127(1):14-26.
    View in: PubMed
    Score: 0.052
  3. Atopic keratoconjunctivitis: A review. J Am Acad Dermatol. 2014 Mar; 70(3):569-75.
    View in: PubMed
    Score: 0.035
  4. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects. Am J Ophthalmol. 2013 Apr; 155(4):615-619, 619.e1-2.
    View in: PubMed
    Score: 0.033
  5. Botulinum toxin injection for the management of refractory filamentary keratitis. Arch Ophthalmol. 2012 Apr; 130(4):446-50.
    View in: PubMed
    Score: 0.031
  6. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea. 2010 Aug; 29(8):871-7.
    View in: PubMed
    Score: 0.028
  7. Integrating restasis into the management of dry eye. Int Ophthalmol Clin. 2006; 46(4):101-3.
    View in: PubMed
    Score: 0.020
  8. Comparative Efficacy of Current Topical Treatments for Dry Eye Disease: A Review of Pivotal Clinical Trials Evaluating Corneal Staining Outcomes. J Ocul Pharmacol Ther. 2025 Aug; 41(6):293-304.
    View in: PubMed
    Score: 0.019
  9. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration. Eye Contact Lens. 2004 Jan; 30(1):2-5.
    View in: PubMed
    Score: 0.018
  10. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj?gren syndrome. Ophthalmology. 1999 Apr; 106(4):811-6.
    View in: PubMed
    Score: 0.013
  11. Advances in the diagnosis and management of keratoconjunctivitis sicca. Curr Opin Ophthalmol. 1998 Aug; 9(4):50-3.
    View in: PubMed
    Score: 0.012
  12. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis. Mol Pharm. 2016 10 03; 13(10):3468-3477.
    View in: PubMed
    Score: 0.011
  13. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol. 1993 Nov 15; 116(5):584-9.
    View in: PubMed
    Score: 0.009
  14. Patient ocular conditions and clinical outcomes using a PROSE scleral device. Cont Lens Anterior Eye. 2013 Aug; 36(4):159-63.
    View in: PubMed
    Score: 0.008
  15. Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol. 1992 Oct; 110(10):1450-4.
    View in: PubMed
    Score: 0.008
  16. Endophthalmitis caused by streptococcal species. Arch Ophthalmol. 1992 Jun; 110(6):798-801.
    View in: PubMed
    Score: 0.008
  17. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005 Oct; 112(10):1790-4.
    View in: PubMed
    Score: 0.005
  18. Infectious keratitis after LASIK. Ophthalmology. 2003 Mar; 110(3):503-10.
    View in: PubMed
    Score: 0.004
  19. Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology. 1993 Sep; 100(9):1358-66.
    View in: PubMed
    Score: 0.002
  20. Postoperative Propionibacterium endophthalmitis. Treatment strategies and long-term results. Ophthalmology. 1993 Apr; 100(4):447-51.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.